These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27106810)

  • 1. Gender Differences in Antihypertensive Treatment: Myths or Legends?
    Muiesan ML; Salvetti M; Rosei CA; Paini A
    High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):105-13. PubMed ID: 27106810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
    Gu Q; Burt VL; Paulose-Ram R; Dillon CF
    Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11.
    Neuhauser HK; Adler C; Rosario AS; Diederichs C; Ellert U
    J Hum Hypertens; 2015 Apr; 29(4):247-53. PubMed ID: 25273858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the Management of Hypertension in Older Populations.
    Pont L; Alhawassi T
    Adv Exp Med Biol; 2017; 956():167-180. PubMed ID: 27815929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011.
    Sarganas G; Neuhauser HK
    Hypertens Res; 2016 Jun; 39(6):457-66. PubMed ID: 26818655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?
    Sindone A; Erlich J; Lee C; Newman H; Suranyi M; Roger SD
    Intern Med J; 2016 Mar; 46(3):364-72. PubMed ID: 26968600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-related differences in the management of hypertension by cardiologists: the PARITE study.
    Mounier-Vehier C; Simon T; Guedj-Meynier D; Ferrini M; Ghannad E; Hubermann JP; Jullien G; Poncelet P; Achouba A; Quéré S; Guenoun M
    Arch Cardiovasc Dis; 2012 May; 105(5):271-80. PubMed ID: 22709468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and Pharmacological Therapy in Women.
    Lodi E; Carollo A; Martinotti V; Modena MG
    High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):147-150. PubMed ID: 29623553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating hypertension in women: open-ended questions and therapeutic options.
    Morganti A
    J Hypertens Suppl; 2002 May; 20(2):S44-6. PubMed ID: 12183851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective.
    Thoenes M; Neuberger HR; Volpe M; Khan BV; Kirch W; Böhm M
    J Hum Hypertens; 2010 May; 24(5):336-44. PubMed ID: 19798089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical appraisal of the guidelines from France, the UK, Europe and the USA for the management of hypertension in adults.
    Stephan D; Gaertner S; Cordeanu EM
    Arch Cardiovasc Dis; 2015; 108(8-9):453-9. PubMed ID: 26113481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.